Papers/PMID:18555574
The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association2008The record
3 findings · 1 compound · 3 endpoints · 3 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
3 findings
rebaudioside A — no detected effect on mean arterial pressure
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Compared with placebo, rebaudioside A did not significantly alter resting, seated SBP, DBP, mean arterial pressure (MAP), heart rate (HR) or 24-h ambulatory blood pressures responses.”
Quoted verbatim from The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure.. - Study
- RCT
- Duration
- 4 weeks
- Dose
- 1000 mg/day rebaudioside A for 4 weeks
- Population
- healthy adults with normal and low-normal blood pressure
The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure.2008PMID:18555574Permalink
rebaudioside A — no detected effect on systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Compared with placebo, rebaudioside A did not significantly alter resting, seated SBP, DBP, mean arterial pressure (MAP), heart rate (HR) or 24-h ambulatory blood pressures responses.”
Quoted verbatim from The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure.. - Study
- RCT
- Duration
- 4 weeks
- Dose
- 1000 mg/day rebaudioside A for 4 weeks
- Population
- healthy adults with normal and low-normal blood pressure
The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure.2008PMID:18555574Permalink
rebaudioside A — no detected effect on diastolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Compared with placebo, rebaudioside A did not significantly alter resting, seated SBP, DBP, mean arterial pressure (MAP), heart rate (HR) or 24-h ambulatory blood pressures responses.”
Quoted verbatim from The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure.. - Study
- RCT
- Duration
- 4 weeks
- Dose
- 1000 mg/day rebaudioside A for 4 weeks
- Population
- healthy adults with normal and low-normal blood pressure
The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure.2008PMID:18555574Permalink